Investors in Jasper Therapeutics, Inc. who experienced losses during the defined class period should be aware of the recent class action lawsuit filed by Rosen Law Firm, as it presents an opportunity for potential recovery.
NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces that an investor filed a class action lawsuit on behalf of purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR), between November 30, 2023 and July 3, 2025, both dates inclusive (the “Class Period”). Jasper is a clinical-stage biotechnology company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigat
Source: Original Press Release
